How a targeted drug kept one patient alive 15 years — but failed to save her friends
A lung cancer patient speaks out about her cutting-edge treatment: “Research is big on tracking survival stats, but quality of life for survivors — not so much.”
We haven't written up this one. STAT News has the full story — the link below goes straight to it.